About Us Advocacy CSHP Network Events Membership Products and Services Programs Resources MY.CSHP.ca  

Award/Grant Programs
Research and Education
Fellows Program
Online Education
Residency Training
Printable Version


Residency Training

CPRB Accredited Programs

Alberta Health Services, CancerControl Alberta
Cross Cancer Institute, 11560 University Avenue
Edmonton, Alberta T6G 1Z2

Tom Baker Cancer Centre, 1331 29 St NW
Calgary, Alberta T2N 4N2

Director: Dr. Tania Mysak, BSP, Pharm D
Director, Practice, AHS Pharmacy Services
Email: Tania.Mysak@ahs.ca

Phone: (780) 735-0770


Cross Cancer Institute:  Melanie Danilak, BSc. Pharm, ACPR, MEd
Pharmacy Clinical Educator
Email: Melanie.Danilak2@ahs.ca 
Phone: (780) 432-8219    
Fax: (780) 432-8407

Tom Baker Cancer Centre:  Frances Cusano, BSc. Pharm, ACPR
Clinical Practice Leader
Email:   frances.cusano@ahs.ca 
Phone: (403) 521-3365            
Fax: (403) 521-3326


Type: General
Focus: Oncology
Established in: 2005
# Positions: 2
App. Deadline: October 28
Starting date: July 4
Est. stipend: approximately $50, 000 per annum

Benefits: Yes

Vacation/holiday leave: 10 paid days

Education/conference leave: Time provided to support residents to attend conferences

Minimum required credentials: Bachelor of Science in Pharmacy & licensure in Alberta

Program highlights: General residency program involving rotations in drug information, medication use systems, leadership and administration and clinical rotations such as internal medicine, hematology/oncology, blood and marrow transplant, pain and palliative care, neuro oncology, pediatric oncology, and breast cancer. As this is a regional program, rotations may be offered at either the Cross Cancer Institute, the Tom Baker Cancer Centre or other AHS hospital sites. Residents must also complete a research project during the year.

Required Rotations: (duration; site choices): Rotations offer the residents experience in the cancer centres and hospitals in Edmonton and Calgary:  
Drug Information: 2 weeks + longitudinal experience; Drug Information North UAH or Drug Information South PLC
Medication Use Systems: 2 weeks; CCI, TBCC
Leadership and Administration: 2 weeks; CCI, TBCC
Acute Care Adult Oncology: 4-6 weeks; CCI, Unit 57 FMC 
Pain and Palliative Care: 4-6 weeks; CCI, TBCC
Hematology/Oncology: 4-6 weeks; CCI, TBCC
Internal Medicine: 4-6 weeks; UAH, MCH, RAH, FMC, PLC
Blood and Marrow Transplant: 4-6 weeks; CCI, TBCC
Undergraduate Clinical Precepting:  4 weeks; CCI,TBCC
Residency Research Project: 8 weeks

Elective Rotations: Chosen based on interests of the resident and the availability of the rotations. There is enough time allotted to allow for one elective rotation of 4-6 weeks’ duration. The rotations listed below are a summary of available rotation sites at the present time. There is a possibility that additional rotation sites may open up with the addition of new practice areas.

  • Neuro oncology (TBCC)
  • Breast Cancer (CCI)
  • Pediatric Oncology:  UAH, ACH
  • Infectious Disease (UAH, RAH)


Type: Alberta Pharmacy Practice Residency Program-CancerControl Alberta
Number of beds: 56 (Cross Cancer Institute) with most clinics operating in an ambulatory setting
Sites: Cross Cancer Institute (CCI), Tom Baker Cancer Centre (TBCC), as well as other hospitals within Alberta Health Services

Residents 2016-2017
Grace Wong (CCI)
Humirah Sultani (TBCC)

Residents 2015-2016
Bianca Au (CCI)
Katherine Fung (TBCC)

Residents 2014-2015
Jenna Foulds (CCI)
Vincent Ha (TBCC)

Residents 2013-2014:
Alastair Ilich (CCI)
Sarah Lutes (TBCC)

Residents 2012-2013:
Janet Quon (CCI)
Julia Warr (TBCC)

Residents 2011-2012:
Kristin Anderson (TBCC)
Kristine Ferguson (CCI)

Residents 2010-2011:
Nadine Lam (CCI)
Nikki Ryan (TBCC)

Residents 2009-2010:
Naureen Sheikh (CCI)

Residents 2008-2009:
Melanie Danilak (CCI)
Stephanie Leong (TBCC)

Residents 2007-2008:
Patrick Yau (CCI)
Louise Delaney (TBCC)

Residents 2006-2007:
Kelly Wills (CCI)
Diana Howard (TBCC)